Journal
ANNALS OF BIOMEDICAL ENGINEERING
Volume 38, Issue 6, Pages 2167-2182Publisher
SPRINGER
DOI: 10.1007/s10439-010-0028-0
Keywords
Osteochondral; Interface; Gradient; Microsphere; Umbilical cord stem cells; PLGA; BMP-2; TGF-beta(1)
Categories
Funding
- Arthritis Foundation
- National Institutes of Health (NIH/NIDCR) [1 R21 DE017673-01]
- NIGMS/NIH Pharmaceutical Aspects of Biotechnology [T32-GM008359]
Ask authors/readers for more resources
Continuous gradients exist at osteochondral interfaces, which may be engineered by applying spatially patterned gradients of biological cues. In the present study, a protein-loaded microsphere-based scaffold fabrication strategy was applied to achieve spatially and temporally controlled delivery of bioactive signals in three-dimensional (3D) tissue engineering scaffolds. Bone morphogenetic protein-2 and transforming growth factor-beta(1)-loaded poly(d,l-lactic-co-glycolic acid) microspheres were utilized with a gradient scaffold fabrication technology to produce microsphere-based scaffolds containing opposing gradients of these signals. Constructs were then seeded with human bone marrow stromal cells (hBMSCs) or human umbilical cord mesenchymal stromal cells (hUCMSCs), and osteochondral tissue regeneration was assessed in gradient scaffolds and compared to multiple control groups. Following a 6-week cell culture, the gradient scaffolds produced regionalized extracellular matrix, and outperformed the blank control scaffolds in cell number, glycosaminoglycan production, collagen content, alkaline phosphatase activity, and in some instances, gene expression of major osteogenic and chondrogenic markers. These results suggest that engineered signal gradients may be beneficial for osteochondral tissue engineering.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available